Biostax Corp (BTAX)

[tjguy]

This is GREAT NEWS!!

I like the following parts:

The Company believes NAFDACs approval of Lodonal in Nigeria will also open the doors to over a dozen other African Nations ...."

Immune Therapeutics Goal is to Capture at Least 20% of Nigerias Addressable Billion Dollar Market for the Treatment of HIV/AIDS within 12-18 Months with Lodonal, its Blockbuster Immunotherapy.

We believe that Lodonal has the potential to become the first affordable non-toxic adjunct therapy that can also offset the side-effects of ART therapy for patients suffering from HIV/AIDS.

The potential market for Lodonal is significant in Nigeria... the second highest HIV/AIDS population in the world.

With Immune Therapeutics recently announced debt restructuring, the company is well positioned to move forward with its business plan, which calls for a significant ramp-up in revenues and achievement of profitability by the end of the fourth quarter.

In addition to Nigeria, the company expects to obtain regulatory approvals in Kenya , Senegal , and Cote dIvoire by the fourth quarter of 2017 or early in 2018.